v3.26.1
Condensed Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest - USD ($)
Total
Common Stock [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Redeemable Noncontrolling Interest [Member]
Beginning balance, value at Jun. 30, 2024 $ 1,000,000 $ 163,823,000 $ (161,912,000) $ (911,000) $ 1,534,000
Beginning balance (in shares) at Jun. 30, 2024   38,062,647      
Equity placements 9,218,000 $ 9,218,000
Equity placements (in shares)   6,369,278      
Equity facility draws 3,191,000 $ 3,191,000
Equity facility draws (in shares)   1,919,250      
Issuance of warrants 2,262,000 $ 2,262,000  
Debt conversions 501,000 $ 501,000
Debt conversions (in shares)   258,347      
Warrant exercises 403 $ 403,000 0 0 0
Warrant exercises (in shares)   230,000      
Option exercises 0 $ 0 0 0 0
Option exercises (in shares)   512      
Class B share conversions 119,000 $ 119,000 (119,000)
Class B share conversion (in shares)   348,085      
Share-based compensation 788,000 $ 788,000
Share issuance costs (2,133,000) (2,133,000)
Income (loss) for the period (7,818,000) (7,818,000) (177,000)
Ending balance, value at Mar. 31, 2025 7,531,000 $ 178,172,000 (169,730,000) (911,000) 1,238,000
Ending balance (in shares) at Mar. 31, 2025   47,188,119      
Beginning balance, value at Dec. 31, 2024 6,891,000 $ 172,235,000 (164,433,000) (911,000) 1,316,000
Beginning balance (in shares) at Dec. 31, 2024   43,671,287      
Equity placements 5,000,000 $ 5,000,000
Equity placements (in shares)   2,577,320      
Equity facility draws 1,328,000 $ 1,328,000
Equity facility draws (in shares)   709,000      
Warrant exercises 403,000 $ 403,000 0
Warrant exercises (in shares)   230,000      
Option exercises 0 $ 0 0 0 0
Option exercises (in shares)   512      
Share-based compensation 6,000 $ 6,000
Share issuance costs (800,000) (800,000)
Income (loss) for the period (5,297,000) (5,297,000) (78,000)
Ending balance, value at Mar. 31, 2025 7,531,000 $ 178,172,000 (169,730,000) (911,000) 1,238,000
Ending balance (in shares) at Mar. 31, 2025   47,188,119      
Beginning balance, value at Jun. 30, 2025 $ 28,323,000 $ 208,551,000 (179,317,000) (911,000) 838,000
Beginning balance (in shares) at Jun. 30, 2025 58,491,196 58,491,196      
Equity placements $ 405,195,000 $ 405,195,000
Equity placements (in shares)   61,006,866      
Equity facility draws 39,434,000 $ 39,434,000
Equity facility draws (in shares)   5,727,662      
Warrant exercises 27,566,000 $ 27,566,000 0 0 0
Warrant exercises (in shares)   19,314,426      
Option exercises $ 1,088,000 $ 1,088,000 0 0 0
Option exercises (in shares) 450,000 369,452      
Class B share conversions $ 58,000 $ 58,000 (58,000)
Class B share conversion (in shares)   417,891      
Private warrant conversions 2,501,000 $ 2,501,000 0
Share-based compensation 3,911,000 3,911,000 0
Share issuance costs (30,069,000) (30,069,000) 0
Income (loss) for the period (42,613,000) (42,613,000) (1,774,000)
Ending balance, value at Mar. 31, 2026 $ 435,394,000 $ 658,235,000 (221,930,000) (911,000) (994,000)
Ending balance (in shares) at Mar. 31, 2026 145,327,493 145,327,493      
Beginning balance, value at Dec. 31, 2025 $ 308,698,000 $ 532,208,000 (222,599,000) (911,000) (650,000)
Beginning balance (in shares) at Dec. 31, 2025   120,774,400      
Equity placements 100,000,000 $ 100,000,000
Equity placements (in shares)   19,999,951      
Equity facility draws 31,634,000 $ 31,634,000
Equity facility draws (in shares)   4,527,662      
Warrant exercises 164,000 $ 164,000 0 0 0
Warrant exercises (in shares)   25,480      
Share-based compensation 824,000 $ 824,000
Share issuance costs (6,595,000) (6,595,000)
Income (loss) for the period 669,000 669,000 (344,000)
Ending balance, value at Mar. 31, 2026 $ 435,394,000 $ 658,235,000 $ (221,930,000) $ (911,000) $ (994,000)
Ending balance (in shares) at Mar. 31, 2026 145,327,493 145,327,493